Synthetic Biology – Products

Celemics co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality,

Sphere Fluidics has announced it has enhanced the capability and performance of its Cyto-Mine® System. The simplified design offers improved functionality to help streamline workflows, reduce costs, increase throughput, and enable high-value clones to be captured in a single run.

Evonetix has announced the appointment of Michael Daniels, PhD, as Head of Product Management. In this role, Dr Daniels will be focused on the development and introduction of Evonetix’s first product, a DNA desktop writer.

A cornerstone of synthetic biology is designing DNA sequences and testing the characteristics and functions of the resultant proteins. Traditional in vivo protein expression workflows can be time-intensive and laborious, and they can fail if the protein is toxic to the host cells.

A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment. Sandia and BioBright are working to develop better security for this new commercial field.

DNA Script has announced a $50 million extension to its Series B financing, bringing the total investment of this round to $89 million, with investors including Agilent, Merck and Danaher.

Sphere Fluidics and Heriot-Watt University have been awarded a grant from Innovate UK to facilitate the development of novel droplet generator instrumentation.

Codexis, Inc., a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce a partnership to engineer enzymes to deliver differentiated and cost-effective solutions for the enzymatic synthesis of DNA.